UPDATE: Cowen Reiterates $150 PT on Novavax (NVAX), Believes 'briefing documents suggest that the vaccine meets all the requirements for approval '
Go back to UPDATE: Cowen Reiterates $150 PT on Novavax (NVAX), Believes 'briefing documents suggest that the vaccine meets all the requirements for approval '| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.05 -0.09 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $9.23 | |||
| Open | $8.13 | 52 Week Low | $1.16 | |||
| Day High | $8.13 | P/E | N/A | |||
| Day Low | $7.92 | EPS | $-0.30 | |||
| Volume | 2,279,572 | |||||
